Conclusions: This is the largest series of surgical intervention for mTAAAs/PRAAs and iTAAAs/PRAAs. They frequently present as ruptures, requiring complex reconstruction, with high 30-day mortality and complications. However, this strategy can be lifesaving when it is performed in high-volume aortic centers with minimal long-term complications.
Objective: Surgeons' contributions to the opioid epidemic have received significant attention in the media. Few data exist, however, of the impact of prior or coexistent opioid use on vascular surgery outcomes. This study aimed to quantify the economic impact of pre-existing opioid dependency in patients undergoing lower extremity bypass surgery.
Methods: Data were collected from 1,132,317 patient admissions for lower extremity bypass in the National Inpatient Sample from years 2002 to 2015. Patients with a concomitant diagnosis of opioid abuse or dependency were identified by International Classification of Diseases, Ninth Revision codes. Matched cohorts of patients with and without opioid dependence were created using coarsened exact matching to control for patients' demographics. Linear regression was used to control for hospital-level factors and to identify differential outcomes for patients with opioid dependency.
Results: There were 3189 (0.3%) patients undergoing lower extremity bypass who were found to have a concomitant opioid use disorder. The incidence of opioid dependency rose over time (0.13% [2002] ; 0.63% [2015] ; P < .001; Fig) . Before matching, opioid-dependent patients were younger (53.9 6 12.3 years vs 66.7 6 12.1 years; P < .001) and more likely to be male (65.2% vs 61.9%; P < .001), to be nonwhite (37.9% vs 24.1%; P < .001), to pay with Medicaid (29.6% vs 7.4%; P < .001), and to fall in the lowest income quartile based on ZIP code (39.6% vs 27.5%; P < .001). After matching, there was no difference in in-hospital mortality (1.7% vs 2.1%; P ¼ .5), myocardial infarction (2.1% vs 2.4%; P ¼ .7), pulmonary embolism (0.8% vs 0.4%; P ¼ .08), or amputation (2.4% vs 1.8%; P ¼ .16). Opioiddependent patients were more likely to have surgical site infections (12.0% vs 5.9%; P < .001), septicemia (5.0% vs 3.3%; P ¼ .03), and acute renal failure (13.0% vs 8.2%; P < .001). Linear regression of matched cohorts revealed that opioid-dependent patients had an increased length of stay (12.5 days vs 9.1 days; P < .001) and increased mean inflation-adjusted cost of $10,608 ($40,127 vs $29,519; P < .001).
Conclusions: Patients with opioid use disorder undergoing lower extremity bypass surgery have staggering increases in length of hospital stay and costs. Furthermore, the rise in the incidence of opioid dependency highlights the importance of early preoperative recognition of this disorder in patients undergoing vascular surgery and opens the opportunity for early intervention. Objective: Treatment of claudication is elective; thus, good outcomes are imperative. The objective of this study was to examine patterns of claudication management and outcomes after peripheral vascular intervention (PVI) for claudication in the Vascular Quality Initiative.
Methods: Patients undergoing PVI for claudication between 2003 and 2017 with adequate follow-up data were included. Primary outcomes were recurrence (ClaudRecur) and repeated procedure (ReProc). Logistic regression and Cox proportional hazards were used. For the proportion of procedures, only centers with >20 procedures and surgeons with >10 procedures in 2016 were included.
Results: In 2016, the proportion of PVI procedures performed for claudication varied by region (11.3%-31.8%), by center (0%-100%), and by surgeon (0%-100%). Preoperative ankle-brachial index was reported in 77%. There were 13,397 patients who met inclusion criteria (mean age, 66 years; 61% male; 27% coronary artery disease; 37% diabetes; 84% hypertension); 45.1% were current smokers, two or more arteries were treated in 14.4%, atherectomy was used in 12.5%, and 28.3% were discharged without an antiplatelet and a statin. Current smoking was associated with increased odds of ClaudRecur (odds ratio [OR] Conclusions: Lack of optimal medical management, use of atherectomy, and treatment of two or more arteries are associated with worse outcomes after PVI for claudication. Given that Society for Vascular Surgery guidelines set a benchmark for the outcome of invasive treatment of claudication at a minimum of 50% likelihood of clinical efficacy for 2 years, these results are concerning and warrant further investigation into factors that influence ClaudRecur after PVI. Objective: There is limited evidence regarding the role of multidisciplinary teams in vascular clinical trials. Best Endovascular vs Best Surgical Therapy for Patients with Critical Limb Ischemia (BEST-CLI), a randomized trial comparing surgical and endovascular revascularization strategies, is structured to foster multidisciplinary collaboration. To evaluate the impact of collaboration, we compared enrollment rates at multidisciplinary and nonmultidisciplinary sites.
Methods: We analyzed 132 BEST-CLI sites open for enrollment. Multidisciplinary sites had investigators belonging to at least two different specialties (vascular surgery and interventional cardiology or radiology). Sites having only vascular surgery investigators were considered single disciplinary. To test our hypothesis, a linear regression model of monthly enrollment rate was constructed considering the following characteristics: multidisciplinary vs single disciplinary and total number of investigators.
Results: Ninety (68%) sites were multidisciplinary and 42 (32%) sites were single disciplinary. At time of analysis, these sites had enrolled 1345 patients. The mean and median monthly enrollment at multidisciplinary sites were 0.30 and 0.24 (range, 0-1.77). The mean and median monthly enrollment at single-disciplinary sites were 0.27 and 0.24 (range, 0-1.30). In the regression model, there was no significant difference in monthly enrollment rates between multidisciplinary and single-disciplinary sites; after adjustment for the total number of investigators, multidisciplinary sites averaged 0.02 fewer enrolled per month (95% confidence interval, À0.13 to 0.09; P ¼ .72). Monthly enrollment rates were significantly higher for sites with more investigators (0.02 higher for each additional investigator (95% confidence interval, 0.00-0.03; P ¼ .0497).
Conclusions: Clinical enrollment rates in randomized trials are affected by multiple factors. After adjusting for the total number of investigators, we found no significant relationship between multidisciplinary status and monthly enrollment rates. Monthly enrollment rate was positively correlated with number of site investigators. Given the importance of enrollment for trial execution, further evaluation of factors that have an impact on enrollment is crucial.
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Predictors of Blunt
Methods: The Trauma Quality Improvement Program (2010-2016) was queried for individuals with blunt trauma. Patients with and without BAAI were compared. Covariates were included in a multivariable logistic regression model to determine mechanisms of injury, examination findings, and concomitant injuries associated with increased risk for BAAI. A multivariable analysis was performed for mortality in patients with BAAI.
Results: From 1,056,633 blunt trauma admissions, 1012 (0.1%) were identified with BAAI. The most common mechanism was motor vehicle accident (MVA; 57.5%). More than half the patients had at least one rib fracture (54.0%) or a spine fracture (53.9%), 20.8% had hypotension on admission, and 7.8% had a trunk abrasion. The average length of stay was 13.4 days and 24.6% required laparotomy, with 6.6% receiving an endovascular repair and 2.9% an open repair. The risk of death in those treated with endovascular vs open repair was similar (P ¼ .28). On multivariable analysis, MVA was the mechanism associated with the highest risk of BAAI (odds ratio [OR], 4.68; confidence interval [CI], 3.87-5.65; P < .001), followed by pedestrian struck (OR, 4.54; CI, ; P < .001). Other factors associated with BAAI included hypotension on admission (OR, 3.87; CI, 3.21-4.66; P < .001), hemopneumothorax (OR, 3.67; CI, 1.16-11.58; P < .001), abrasion to the trunk (OR, 1.49; CI, 1.15-1.94; P ¼ .003), 
